Skip to main content
. 2022 Nov 24;13:1010579. doi: 10.3389/fphar.2022.1010579

FIGURE 5.

FIGURE 5

CircRNAs can serve as biomarkers or therapeutic targets. (A) Examples of circRNAs as potential biomarkers in AML. (B) The studies about siRNAs targeting oncogenic circRNAs in patient-derived xenograft mouse model of AML and CRISPR/Cas13 targeting oncogenic circRNAs in AML remain unclear.